Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS SEPTEMBER ISSUE PUBLISHED
  • SEPTEMBER 2020 Issue has been successfully launched on 1 September 2020.

Abstract

NANOTECHNOLOGY BASED SI RNA’S THEARPY

*Rawat Swati1, Malviya Sapna2

1SND College of Pharmacy, Yeola, Nashik (M.S) - 423401
2Modern College of Pharmacy, Indore (M.P.), 452001

ABSTRACT

Nanotechnology is a multidisciplinary field, which covers a vast and diverse array of devices derived from engineering, biology, physics and chemistry. Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter). Nanobiotechnology, an integration of physical sciences, molecular engineering, biology, chemistry and biotechnology holds considerable promise of advances in pharmaceuticals and healthcare. Benefits of nanotechnology, though limited, have driven efforts to develop advanced nanoparticles. This is particularly the case for targeted nucleic acid (gene) therapeutics based on short interfering ribonucleic acid (siRNA), which is a new gene inhibitor that is highly potent and selective that is relevant to nanobiotechnology. Need of an hour is to develop an innovative medicine i.e. (Nanomedicine) because of their impact on health care and regulation. One of the ‘revolutionary’ properties of siRNA is its potency, stability, and low level of nonspecific activity when synthesized without chemically stabilized RNA. This is an argument for focusing efforts to deliver siRNA as a therapeutic modality not by medicinal chemistry but by packaging.

Keywords: siRNA- short interfering ribonucleic acid, nanometer- one billionth of a meter.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More